BREAKING NEWS: CDC committee DELAYS vote on whether or not to recommend lifting the pause of the Johnson & Johnson vaccine because it needs to collect more data on adverse side effects
- The Advisory Committee on Immunization Practices met on Wednesday to discuss the Johnson & Johnson coronavirus vaccine
- It came after the CDC and the FDA recommended that rollout of the vaccine be paused after multiple reports of rrare, but serious, blood clots
- The committee is delaying its vote until a later date because members wanted more data before proceeding with a decision
A Centers for Disease Control and Prevention (CDC) committee has delayed its vote on whether or not to recommend lifting the pause of the Johnson & Johnson coronavirus vaccine.
The meeting was convened after the CDC and U.S. Food and Drug Administration (FDA) recommended that clinicians pause use of the Johnson & Johnson vaccine after nine reports of rare, but serious, blood clots out of 7.2 million vaccinations.
Two occurred in clinical trials and seven occurred after the vaccine was approved for emergency use authorization.
Eight were among women ages 18 to 59. One woman died and two are currently in critical condition.
Members of the Advisory Committee on Immunization Practices (ACIP), which develops guidelines for vaccine administration as well as schedules, appeared to want more data before proceeding with a decision.
The CDC’s Advisory Committee on Immunization Practices is delaying its vote on recommendations about the Johnson & Johnson vaccine until more data are available (file image)
This is a breaking news story and will be updated.